Hi all
pretty new to all this. I have pumped some into Deltex - looks like a strong product with good growth. Could be a steady gainer.
Does anyone else have this, and anyone have some research on it? Someone with more experience than me!
thanks in advance.
Grajul

All it needs is for the Bear of Dialog to turn up. Anyone for a short?

A short? Mine's a double G&T, thanks Kayak!

For several weeks this thread was relatively quiet. Now it has come to life. Just a pity the more sensible comments are being lost in a sea of none Deltex input.

THE COUNT--->GREEKMAN

Don't worry, there will be plenty of time for more sensible comments. Yesterday was just a bit of light hearted banter by a few people who kow each other and it was in the evening when the market was closed.

There was a bit of shirt pulling going on, that's all. If you read between the lines, you may suss what it was about.

THE COUNT!

greekman...agree with your sentiments....Deltex now need to announce good deals/contract wins/sales.. maybe that'll give peeps something to focus on,,,

The Count,

OK I will pull my horns in. It is just that you can't help being frustrated with an organization such as the NHS.

Skyhigh ,

Thanks for that. The next 6 to 12 months will imho be a very important time for Deltex. That will be the time scale for feedback from their overseas push.

THE COUNT--->GREEKMAN

Look at it another way, and it is also the way that the company itself view this.

If it was easy to break in and sell to any health service, but the NHS in particular in this case, then it would also be easier for a similar technology to move in and to perhaps start to usurp our position.

As it stands, it is damned difficult to get the sales, but those sales we have got, will go on generating the repeat sales of probes for many years to come and with the added bonus that anyone else looking to try and move into our 'space' will have the massive problem of breaking into the NHS that we have had, but unlike us, they will have to also prove themselves overwhelmingly superior to the incumbent technology which, more and more with each passing day, is ours.

Yes its tough to break in and make all the right moves, but once in, our turnover becomes far more sustainable and safe than many other businesses. The sustainablity and repeatability along with the strong growth to come in our revenues is what should also sustain this stock on a high PER when we move to that method of valuation.

THE COUNT!

THE COUNT--->GREEKMAN

....I almost forgot. Talking of the stake taken by Mr John Christou....that surname looks pretty Greeky/Cyprioty to me....is he your good self? Go on, you can share that with your friends on here. :-)

Regards,

THE COUNT!

Not saying, but if I had that sort of cash???. As to your comments re Deltex/NHS I fully agree that we will get there. Perhaps Deltex are on the NHS waiting list and we all know what that means, we will get a result if the patient doesn't die first..

The count posts 232

"I jest you not though, current clinical demand in the UK alone is running at a factor of ten times actual usage. That is in excess of 300,000 probes in the potential pipeline....or around an extra 18m of annual turnover extra. This is business that is won, if only the docs could get the funding for it. That could generate profits of 8m - 10m pa conservatively speaking. On a present market cap of around 15m, I think you should be able to see why it could be interpreted as being a bit on the cheap side."

Where do you get this from? Thought you had more than a "simplistic/token" understanding!!!!! Also with your sales predictions one probe might cost 60 each however an order of say even 10,000 probes would be discounted...

THE COUNT--->EXPLOSIVE

Why do you assume I don't have more than a "simplistic/token" understanding!!!!! ?

What I tell you is accurate.

When I invest, I like to get off my fat arse every once in a while, and where possible, attend AGMs regularly and meet management. I also am a client of DEMG's house broker, Charles Stanley so I get the research regularly.

I also know Nigel Keen, the chairman and have known him for about 8 years now. My two biggest holdings are DEMG and ASD....he is the chairman of both.

I also helped to arrange the funding round back in September last year, introducing, via my own investor friends and myself, 300k of the 500k invested in that round. It was I that made the demand of the management that if we came in on the investment, I also had to see strong director buying as a result. All you have to do is go back and check the director buying that accompanied that cash injection to see that they honoured their word.

Obviously, we invested further monies because of a series of presentations to potential investors both in their home town of Chichester and here in London.

So, don't laugh and fall off your chair when I say 'trust me, I know what I am talking about'. Because I will qualify that a bit further for investors, that despite 'knowing what I am talking about', there are still no guarantees in the stockmarket....all you can do is better your odds for eventual success.

But now to your questions which you seemed to throw in alongside your loose comment about my being simplistic and having no more than token understanding. If you bothered to go out and do some research yourself, starting with just attending an AGM, you would have had one of those questions answered for you directly by the board. It was in answer to my question about the current state of clinical demand. They confirmed it. Of course, they could be lying.

Also, when I visited the company, I actually suggested that they drop the prices of their monitors to try and create further demand in the NHS. The response was that NHS demand was very inelastic...or in other words, it didn't depend on the price, it was other factors....such as the rampant bureaucracy. I think they have done their homework on this.

And if you really knew how this works, you would also know that no single health authority would order 10,000 probes in one hit...it is a pay as you go. Their top used monitors are currently using around 10 plus probes per month and a hospital that has adopted the CardioQ as a standard of care may have 10 - 15 monitors at most. But even if somehow the NHS decided to order medical devices centrally, for the whole country, the probe price, really is not the main driver when equated to the massively disproportionate cost savings that can accrue to the NHS....it is a drop in the ocean. It is the NHS's incompetence that is at work here.

But probe prices may well come down when the figures start to get really silly, but Iwas told that would be because of potential economies of scale in their production. Anyway, I don't see your point. Even if probes were discounted today by 15 a shot, the profits generated would still be enough to multibag this present SP. Is that not enough for you?

I am not going to add much more for now as I want to include a lot of what I have to say within the more comprehensive report I am going to eventually write up on the company.

Hope that at least answers your present concerns. I can understand your cynicism, but if you feel that strongly about a stock, then I would suggest you do a bit more of your own research.

THE COUNT!

Count - If you really have had so much input into fund raising and are as close to the board as you suggest then maybe you can definitivly answer the question on where sales are with the private sector? The private sector has no shortfalls in budget but hasn't adopted Deltex's technology, why not?

THE COUNT--->EXPLOSIVE

I can answer that too, but I won't. I'll do so when I decide, not whenever you decide to fire off one question after another.

Try and put yourself in my position for a moment.

You see a poster who doesn't even hold the stock, come onto a thread and constantly negates what is being said. This poster keeps asking questions, and they are answered in as great a detail as anyone could reasonably expect, yet this poster doesn't even acknowledge the contribution you make in responding to his questions, and he then fires another salvo of questions rather than even show a modicum of appreciation for the efforts in anwering the previous ones.

Would you even bother responding to him?

I'm not interested mate. If you really have so many questions to ask, for a non holder of stock, I would suggest you stop asking me questions and either do some research yourself or even easier, don't buy the fucking stock.

Just a little additional point to other posters regarding my previous post....Deltex recently, actually put up the cost of their monitors by 1,000 to 7,000 a piece. The result? UK monitor sales were, in the first quarter, running at over half as many as the whole of last year. The price is not the issue here.

The NHS will spend the money once it gets through the roundabout approvals process. They are also slowly coming round to the fact that they should also be adopting more cost saving technology...something that is pretty obvious to most of us...but they are dragging their feet as per usual. This product saves big money and reduces morbidity....good for the patient....good for the health service. The rest is just down to time.

THE COUNT!

The Count - Why do you persit to insult and think your superior to other posters on this thread when your not. Your the one claiming to have all the knowledge and answers and consistantly ramping the stock. If Deltex were in the position you describe you'd easily be able to back up your posts/claims.

I'll waste no more time with you, obviously as your full of shit!!

THE COUNT--->EXPLOSIVE

No mate, I don't think I'm superior to anyone. But one thing I have always done in the past, is when someone responds to any questions I have had, time and time again, I at least have the common decency of acknowledging the contribution. Is it me who is superior?

As to ramping, you are having a laugh aren't you. I have been buying this stock for 2 years. I think I'm a bit beyond ramping. I tell it as I understand it and as it is. what I have posted is factual according to what is in the market and according to conversations with management and according to Charles Stanley research. I'm sharing that.

All you seem to have done is ask question after question and carrying a negative slant. perhaps you should justify your own points in the sort of detail I have done so otherwise you could easily be construed as a deramper.

I've backed up my posts you twat. Perhaps if you actually saw the written word that is put in front of you, and wiped away the shit from your eyes that your obvious hidden agenda creates, you will see that already I have posted more factual arguments than your constant stream of questioning and negative innuendo.

THE COUNT!

The Count - 23 May 2006 11:33 - 256 of 256
THE COUNT--->EXPLOSIVE

No mate, I don't think I'm superior to anyone

Believe him Ex, coz Im Superior to him for starters!!!! ;)

I GO FORTH while he sits on the loo!!

The Count, sorry for the tardy reply, pressure of work, no I can honestly say I do not know J. Christou, however putting together comments made recently on this thread and the info content of an e-mail I received from the co, I do believe he posts here. Would you agree?
2517

Why do posters become personal. And also why bother replying to those that do. By reply I don't mean answering queries or comments but by lowering yourself to their standard. I thought these threads were for grown ups. No one is interested in personal spats.

THE COUNT--->2517GEORGE

Now be careful George. You are getting a little warmer I think. :-) It's all in the surname and the name of a certain book isn't it? Cryptic I know.

In response to my little outburst in the last post, I have been consistent with my comments on this stock for well over a year. I have always told people as well that this is a long term play and that nobody knows when a large jump in orders will come, but ultimatley, you have to judge anything on the facts in front of you allied with company research and statements from the company as well as from direct discussions where it has been possible to have those.

Of course, the whole world could still be lying....but then I would call that person a little more of a cynic than myself.

This stock is not going to explode tomorrow or the day after, but anyone who denies the steadily building argument from one clinical trial to the next, along with an ever greater number of intensivists, anaethesiologists and surgeons who now want to use the technology, along with a statement by NICE (The National Institute for Clinical Excellence which was established to advise both government and the medical profession) that this does not come under their remit and they regard it as a 'standard of care' along with clinical demand far outstripping supply....well, I would call those people, in the absence of sound arguments to the contrary, at the very least, deramper.

What is non factual about what I have just said? That is not a ramp. That is a statement of fact and research.

Oh, and here is another fact (those that knock this stock seem to be remarkably devoid of facts), Charles Stanley have brought out yet another note today reiterating their strong buy recommendation along with further comments on the recent news from Scotland of the results of a clinical audit at the Royal Alexandria Hospital in Paisley. Of course, a certain poster would argue that I shouldn't be posting that up as I am 'ramping'.

When is a ramp a ramp, and when is it just a case of someone sharing good info with other fellow investors?

Regards,

THE COUNT!